Navegar has made a follow-on investment in Swiss-based Dali Discount, the first hard discounter in Southeast Asia. Navegar is a Manila-based private equity firm that provides growth capital to established companies. Dali Discount is the
Tags :Simone Ehrsam
The automotive supplier BorgWarner has acquired the Switzerland-based Drivetek. The transaction has an enterprise value of up to CHF 35 million, of which CHF 25 million was delivered at closing. An additional CHF 10 million could be paid
Credit Suisse Asset Management has sold its minority stake in Energy Infrastructure Partners to the company’s co-founders and managing partners for an undisclosed consideration. Energy Infrastructure Partners was established in 2014 as a joint venture
ABB has successfully completed the spin-off of Accelleron Industries which operates ABB’s former turbocharger division. Accelleron’s shares have been admitted to start trading on SIX Swiss Exchange in Zurich, under the ticker symbol “
Navegar made a substantial investment in Swiss-based Dali Discount, the first hard discounter in Southeast Asia. Navegar is a Manila-based private equity firm that provides growth capital to established companies. Lenz & Staehelin has advised
ImmunOs Therapeutics has closed an oversubscribed Series B financing round totaling USD 74 million. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by new investors Mission BioCapital, GL
Climeworks signs an equity round of CHF 600 million (USD 650 million). The financing is co-led by Partners Group (acting on behalf of its clients) and GIC, with further participation from Baillie Gifford, Carbon Removal Partners, Global
On January 27, 2022, the Constellation V Fund and the minority shareholders sold 75% of the shares in Swiss E-Mobility Group (Holding) AG to TVS Motor Company. The SEMG group is a market-leading provider of e-mobility solutions within
TVS Motor Company announced today that it has acquired a majority stake in Swiss E-Mobility Group (SEMG) from Constellation Capital and certain minority shareholders in an all-cash transaction. SEMG is a market leading provider of
Novartis has entered into an agreement to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a consideration of USD 20.7 billion. Novartis had acquired the stake between 2001 and 2003 for approximately USD 5
